Category Archives: Alaune

Ethique et intégrité scientifiques

Il y a plusieurs mois de cela, Pierre Corvol remettait un rapport portant sur le "Bilan et des proposition de mise en oeuvre de la charte nationale d'intégrité scientifique" à Thierry Mandon, alors secrétaire d'Etat chargé de l'Enseignement Supérieur et de la Recherche. Ce rapport débute ainsi: La recherche est un superbe métier, pratiqué avec rigueur et honnêteté par l’immense... Read more »

Improved prognosis in NSTEMI patients

A recent publication from Team 5 has been released in Circulation demonstrates that patients with high risk non–ST-segment–elevation myocardial infarction (NSTEMI) that undergo coronary angiography within the initial 12 hours after admission had a lower risk of ischemic outcomes at 180 days. Timing of Angiography and Outcomes in High-Risk Patients With Non–ST-Segment– Elevation Myocardial Infarction Managed Invasively Insights From the TAO Trial (Treatment… Read more »

Dominique Le Guludec appointed head of the Haute Autorité de Santé

Dominique Le Guludec, Professor of Biophysics and Nuclear Medicine at the UFR of Medicine at Paris Diderot University, Director of the Department of Nuclear Medicine and Biophysics at Bichat Hospital – Claude Bernard, APHP and Head of the Imaging Team Cardiovascular in the Translational Vascular Research Laboratory, has just been appointed head of the Haute Autorité de Santé (HAS). Dominique… Read more »

ACTICOR biotech first-in-human clinical trial in healthy volunteers

Acticor Biotech, a clinical stage biotechnology company (raised on the basis of a work initiated in Team 6 of U1148) involved in the acute phase of thrombotic diseases, including stroke and myocardial infarction, today announced the agreement of Dutch Authorities for the initiation of a phase I clinical trial in healthy volunteers with its drug candidate, ACT017. ACT017 is a… Read more »

D Letourneur granted the 2017 Asian Polymer Association (APA)’s Jubilee Award

Didier Letourneur (Director of LVTS, head of Team 3) has been awarded the 2017 Asian Polymer Association (APA)’s Jubilee Award. APA was founded in 2007 at the premises of Indian Institute of Technology, New Delhi, India, www.asianpolymer.org. The society involves academicians, scientists and technologists from all over the Asian countries providing a well knitted structure of the society. Vision of… Read more »

Prof G Jondeau, coordinator of VASCERN

Prof Guillaume JONDEAU (Team 2) is the corrdinator of VASCERN, the European Reference Network on Rare Multisystemic Vascular Diseases. “The VASCERN project aims to facilitate and improve diagnosis, treatment and care for ALL patients suffering from Rare Multisystemic Vascular Diseases, thus enhancing access to care, and improving quantity and quality of life of these patients. Networking, sharing and spreading our expertise,… Read more »

Signature of the SAVE-BRAIN and SURVI MSD-Avenir projects

On the 18th April 2017, D Blazy (Président du Conseil Scientifique de MSD-Avenir) on the behalf of C Schiever (Président du CA de MSD-Avenir), M Hirsch (Directeur Général de l’AP-HP), the Prof Y Levy (Président Directeur Général de l’INSERM), in the presence of the Prof P Ruszniewski (Doyen de l’UFR de médecine de l’Université Denis Diderot) and of F Crémieux (Directeur… Read more »

RHU call results: LVTS involved in 5 granted projects!

The ‘RHU‘ (Recherche Hospital Universitaire) action is to support translational research projects in health or clinical research, which are to be based on fundamental research in biology, epidemiology, social science or health economics and extend for a benefit for the care of patients, improving the understanding of diseases, more effective and better tolerated treatments, or a performance improvement of care systems. The… Read more »

Early detection of strokes

Télématin broadcasted on the 13rd May 2016 an interview from Prof Pierre Amarenco (Team 5) where it is explained why we should detect stroke as soon as possible. This is related to a paper published this year by P Amarenco et al (N Engl J Med 2016. 374:1533) describing the results obtained from the ‘TIAregistry.org’ project that was designed to establish the contemporary profile, etiologic… Read more »

Prof. D Le Guludec appointed chairperson of the board of Directors of IRSN

PhD in Biophysics, Dominique Le Guludec is Professor of Biophysics and Nuclear Medicine at University Paris 7. She is head of the Department of Nuclear Medicine, Hôpital Bichat, AP-HP, Paris, since 1994. She is also head of a research team of our Inserm Unit 1148, member of the Executive Committee of the EANM, and member of the National Council of… Read more »

FACT: French Alliance for Cardiovascular Trials

The FACT (French Alliance for Cardiovascular Trials) network, chaired by Prof PG Steg (LVTS Team 5) has been selected as an « Investigative Network Initiative » and will receive a 5-year financial support from the F-CRIN (French part of ECRIN – European Clinical Research Infrastructures Network). FACT is an academic research network that federates more than 20 sites throughout France… Read more »

Didier Letourneur at the French Parliament

Over the next five years, a large number of biological drug patents will fall into the public domain. Already, many pharmaceutical companies develop and put on the drug market “Biosimilars” on the same pattern as for the generic chemical drugs. Because substantial savings are expected with this interchangeability, a public audition was held at the French Parliament on 29 January… Read more »